BBOT Earnings BridgeBio Oncology Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–6 of 6
| Q1 2026 | 2026-03-31 | -526.11 | 2026-05-12 | 10-Q |
| FY 2025 | 2025-12-31 | -4.30 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -6.49 | 2025-11-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -54.23 | 2026-05-12 | 10-Q |
| FY 2025 | 2024-12-31 | -5756.41 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -4922.72 | 2025-11-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.